NovoCure Ltd — Director's Dealing 2021

Mar 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-02-27

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-27	Ordinary Shares	M	7715	$149.10	Acquired	150415	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-27	Restricted Stock Units	$0.0	M	7715	Disposed		Ordinary Shares (7715.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.